RA: Treat-to-target strategy improves likelihood of reaching treatment targetsFebruary 1, 2021Rheumatoid Arthritis
MRI-targeted treatment strategy: A positive predictor for remission in RAFebruary 1, 2021Rheumatoid Arthritis
Hydroxychloroquine use not linked to increased risks for psychiatric eventsFebruary 1, 2021Rheumatoid Arthritis
Efficacy of filgotinib in patients with RA with limited or no methotrexate exposureFebruary 1, 2021Rheumatoid Arthritis
CVD and CV risk factors linked to increased dementia risk in patients with RAFebruary 1, 2021Rheumatoid Arthritis
Elevated disease activity, cytokine levels linked to diabetes risk in RAFebruary 1, 2021Rheumatoid Arthritis
Hydroxychloroquine use not linked to heart failure risk in patients with RAFebruary 1, 2021Rheumatoid Arthritis
Rheumatology NewsLung disease raises mortality risk in older RA patientsJanuary 27, 2021Rheumatoid Arthritis
Rheumatology NewsArthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’January 15, 2021COVID-19 UpdatesRheumatoid Arthritis
Inflammation of juxta-articular soft tissues could be an early feature of RAJanuary 6, 2021Rheumatoid Arthritis
